| Transactions | |||
| All | Buy | Sell | Option Exercise |
Filer's Name |
Relationship/ Title |
Trans. Date |
Trans. Type |
Ownership Type |
Security Type |
Shares |
Price |
Trans. Value |
Total Shares Owned |
| Shannon James Samuel | Director | 03/26/2026 | AP | Direct | COM | 5,000 | $8.79 | $43,950.00 | 10,000 |
| Frankenfield Christopher James | Chief Financial Officer | 01/02/2026 | DS | Direct | COM | 7,030 | $0.64 | $4,521.70 | 24,766 |
| Brennan Kevin M. | SVP, FINANCE AND ACCOUNTING | 01/02/2026 | DS | Direct | COM | 1,826 | $0.64 | $1,174.48 | 6,371 |
| Russo Rene | PRESIDENT AND CEO | 01/01/2026 | AM | Direct | COM | 44,250 | $0.00 | $0.00 | 325,422 |
| Frankenfield Christopher James | Chief Financial Officer | 01/01/2026 | AM | Direct | COM | 19,375 | $0.00 | $0.00 | 31,796 |
| Brennan Kevin M. | SVP, FINANCE AND ACCOUNTING | 01/01/2026 | AM | Direct | COM | 5,000 | $0.00 | $0.00 | 8,197 |
| Luptakova Katarina | CHIEF MEDICAL OFFICER | 01/01/2026 | AM | Direct | COM | 16,625 | $0.00 | $0.00 | 33,250 |
| Shannon James Samuel | Director | 06/17/2025 | AP | Direct | COM | 25,000 | $0.69 | $17,215.00 | 70,000 |
| Russo Rene | PRESIDENT AND CEO | 06/16/2025 | AP | Direct | COM | 36,289 | $0.68 | $24,680.15 | 281,172 |
| Shannon James Samuel | Director | 06/16/2025 | AP | Direct | COM | 45,000 | $0.69 | $30,870.00 | 45,000 |
| Brennan Kevin M. | SVP, FINANCE AND ACCOUNTING | 01/02/2025 | DS | Direct | COM | 1,803 | $0.98 | $1,773.61 | 3,197 |
| Frankenfield Christopher James | Chief Financial Officer | 01/02/2025 | DS | Direct | COM | 6,954 | $0.98 | $6,840.65 | 12,421 |
| Brennan Kevin M. | SVP, FINANCE AND ACCOUNTING | 01/01/2025 | AM | Direct | COM | 5,000 | $0.00 | $0.00 | 5,000 |
| Russo Rene | PRESIDENT AND CEO | 01/01/2025 | AM | Direct | COM | 44,250 | $0.00 | $0.00 | 244,883 |
| Luptakova Katarina | CHIEF MEDICAL OFFICER | 01/01/2025 | AM | Direct | COM | 16,625 | $0.00 | $0.00 | 16,625 |
| Frankenfield Christopher James | Chief Financial Officer | 01/01/2025 | AM | Direct | COM | 19,375 | $0.00 | $0.00 | 19,375 |
| Gilead Sciences, Inc. | Other | 12/18/2024 | AP | Direct | COM | 1,759,978 | $1.04 | $1,830,377.12 | 9,105,451 |
| 1   You are at page 1 of 1 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
![]() |
Send to Excel | |||||||